• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune checkpoint inhibitors: here to stay.

作者信息

Carvalho Filomena Marino, Estevez Diz Maria Del Pilar, Carvalho Jesus Paula

机构信息

Department of Pathology, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

出版信息

Transl Cancer Res. 2023 Oct 31;12(10):2438-2441. doi: 10.21037/tcr-23-1343. Epub 2023 Oct 20.

DOI:10.21037/tcr-23-1343
PMID:37969375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10643939/
Abstract
摘要

相似文献

1
Immune checkpoint inhibitors: here to stay.免疫检查点抑制剂：将持续存在。
Transl Cancer Res. 2023 Oct 31;12(10):2438-2441. doi: 10.21037/tcr-23-1343. Epub 2023 Oct 20.
2
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.两种途径的故事：DNA 错配修复缺陷和微卫星不稳定高的子宫内膜癌中免疫检查点抑制剂的综述。
Cancer. 2024 May 15;130(10):1733-1746. doi: 10.1002/cncr.35267. Epub 2024 Feb 29.
3
[Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].[子宫内膜癌分子分类中错配修复及微卫星不稳定性状态的综合评估]
Zhonghua Fu Chan Ke Za Zhi. 2023 Oct 25;58(10):755-765. doi: 10.3760/cma.j.cn112141-20230711-00316.
4
Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.子宫内膜抽吸物中高度敏感的微卫星不稳定性和免疫组织化学评估作为林奇综合征中癌症风险个体化的工具。
Mod Pathol. 2023 Jul;36(7):100158. doi: 10.1016/j.modpat.2023.100158. Epub 2023 Mar 12.
5
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.遗传性和散发性错配修复缺陷型子宫内膜癌具有独特的免疫景观。
Front Immunol. 2020 Jan 9;10:3023. doi: 10.3389/fimmu.2019.03023. eCollection 2019.
6
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.错配修复/微卫星不稳定不一致型子宫内膜癌的特征。
Cancer. 2024 Feb 1;130(3):385-399. doi: 10.1002/cncr.35030. Epub 2023 Sep 26.
7
Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer cases.免疫组织化学在散发性子宫内膜癌病例的腺癌及背景子宫内膜中检测错配修复蛋白和微卫星不稳定性的应用价值。
J Obstet Gynaecol Res. 2019 Oct;45(10):2037-2042. doi: 10.1111/jog.14061. Epub 2019 Jul 15.
8
Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer.微卫星不稳定性是子宫内膜癌中免疫检查点抑制剂的生物标志物。
Oncotarget. 2017 Dec 31;9(5):5652-5664. doi: 10.18632/oncotarget.23790. eCollection 2018 Jan 19.
9
Microsatellite instability and oncological outcomes in Thai patients with endometrial cancer.泰国子宫内膜癌患者的微卫星不稳定性与肿瘤学结局
J Obstet Gynaecol. 2022 Oct;42(7):3117-3123. doi: 10.1080/01443615.2022.2106557. Epub 2022 Aug 5.
10
Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.通过免疫组织化学检测DNA错配修复（MMR）缺陷可有效诊断子宫内膜癌中的微卫星不稳定性（MSI）表型。
Gynecol Oncol. 2015 May;137(2):306-10. doi: 10.1016/j.ygyno.2015.01.541. Epub 2015 Jan 28.

本文引用的文献

1
Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.根据DNA错配修复蛋白状态的子宫内膜癌的临床病理特征
Heliyon. 2023 Jun 22;9(6):e17495. doi: 10.1016/j.heliyon.2023.e17495. eCollection 2023 Jun.
2
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab.晚期子宫内膜癌的靶向治疗：聚焦帕博利珠单抗
Onco Targets Ther. 2023 Jun 2;16:359-369. doi: 10.2147/OTT.S368050. eCollection 2023.
3
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.度伐利尤单抗治疗原发性晚期或复发性子宫内膜癌。
N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27.
4
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.帕博利珠单抗联合化疗治疗晚期子宫内膜癌。
N Engl J Med. 2023 Jun 8;388(23):2159-2170. doi: 10.1056/NEJMoa2302312. Epub 2023 Mar 27.
5
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.帕博利珠单抗治疗微卫星高度不稳定或错配修复缺陷型癌症：来自 II 期 KEYNOTE-158 研究的更新分析。
Ann Oncol. 2022 Sep;33(9):929-938. doi: 10.1016/j.annonc.2022.05.519. Epub 2022 Jun 6.
7
Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.当代子宫内膜癌林奇综合征的筛查：KEM 经验。
Arch Gynecol Obstet. 2021 Oct;304(4):975-984. doi: 10.1007/s00404-021-06006-w. Epub 2021 Mar 12.
8
Complete Clinical Response in Stage IVB Endometrioid Endometrial Carcinoma after First-Line Pembrolizumab Therapy: Report of a Case with Isolated Loss of PMS2 Protein.一线帕博利珠单抗治疗后IVB期子宫内膜样腺癌出现完全临床缓解：1例PMS2蛋白单独缺失病例报告
Case Rep Oncol. 2020 Sep 7;13(3):1067-1074. doi: 10.1159/000510000. eCollection 2020 Sep-Dec.
9
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).卡铂和紫杉醇治疗晚期子宫内膜癌：一项 III 期试验（NRG Oncology/GOG0209）的最终总生存和不良事件分析。
J Clin Oncol. 2020 Nov 20;38(33):3841-3850. doi: 10.1200/JCO.20.01076. Epub 2020 Sep 29.
10
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.帕博利珠单抗治疗非结直肠癌高度微卫星不稳定/错配修复缺陷型癌症患者的疗效：来自 II 期 KEYNOTE-158 研究的结果。
J Clin Oncol. 2020 Jan 1;38(1):1-10. doi: 10.1200/JCO.19.02105. Epub 2019 Nov 4.